Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1384961

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1384961

LAMEA Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End User (Diagnostic Laboratories, Hospitals & Clinics), By Technology, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Non-invasive Prenatal Testing (NIPT) Market would witness market growth of 21.4% CAGR during the forecast period (2023-2030).

This cutting-edge technology allows for ultra-sensitive and accurate analysis of cell-free DNA. It can potentially identify rare genetic mutations and structural chromosomal abnormalities, further increasing the diagnostic power of NIPT. Innovations are being made to enhance the foetal fraction in maternal blood, which can improve the accuracy of NIPT results, especially in cases where the foetal fraction is low. Some researchers are exploring the integration of multinomic profiling, which involves analyzing various molecular markers in maternal blood, such as microRNA, proteins, and DNA. This multi-faceted approach can provide a more comprehensive view of foetal health.

NIPT is used not only for genetic screening but also for the early detection of pregnancy complications like preeclampsia and gestational diabetes. This expanded application can help healthcare providers intervene earlier and improve pregnancy outcomes. Advances in telehealth and remote monitoring technology allow pregnant individuals to undergo NIPT and receive results from the comfort of their homes, reducing the need for in-person appointments. Some researchers are looking into how NIPT may be used to evaluate how environmental and lifestyle factors affect foetal development and reveal how they might affect health consequences.

The Brazilian government has implemented several initiatives and programs to boost healthcare investments and improve the healthcare system in the country. Unified Health System (Sistema Unico de Saude - SUS) is Brazil's public healthcare system, providing free healthcare services to all citizens. The government continuously invests in SUS to improve infrastructure, expand healthcare coverage, and increase the availability of essential medicines. Therefore, the increase in healthcare investments across LAMEA region countries poses lucrative prospects for the growth of the regional market.

The Brazil market dominated the LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $286.5 Million by 2030. The Argentina market is showcasing a CAGR of 22.1% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 21.1% during (2023 - 2030).

Based on Product, the market is segmented into Consumables & Reagents, and Instruments. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics. Based on Technology, the market is segmented into Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Consumables & Reagents
  • Instruments

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals & Clinics

By Technology

  • Next Generation Sequencing (NGS)
  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Rolling Circular Amplification

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Illumina, Inc.
  • Natera Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Product
    • 1.4.2 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Application
    • 1.4.3 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by End User
    • 1.4.4 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Technology
    • 1.4.5 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product

  • 4.1 LAMEA Consumables & Reagents Market by Country
  • 4.2 LAMEA Instruments Market by Country

Chapter 5. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application

  • 5.1 LAMEA Trisomy Market by Country
  • 5.2 LAMEA Microdeletion Syndrome Market by Country
  • 5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User

  • 6.1 LAMEA Diagnostic Laboratories Market by Country
  • 6.2 LAMEA Hospitals & Clinics Market by Country

Chapter 7. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology

  • 7.1 LAMEA Next Generation Sequencing (NGS) Market by Country
  • 7.2 LAMEA Microarray Market by Country
  • 7.3 LAMEA Polymerase Chain Reaction (PCR) Market by Country
  • 7.4 LAMEA Rolling Circular Amplification Market by Country

Chapter 8. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country

  • 8.1 Brazil Non-invasive Prenatal Testing (NIPT) Market
    • 8.1.1 Brazil Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.1.2 Brazil Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.1.3 Brazil Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.1.4 Brazil Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.2 Argentina Non-invasive Prenatal Testing (NIPT) Market
    • 8.2.1 Argentina Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.2.2 Argentina Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.2.3 Argentina Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.2.4 Argentina Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.3 UAE Non-invasive Prenatal Testing (NIPT) Market
    • 8.3.1 UAE Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.3.2 UAE Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.3.3 UAE Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.3.4 UAE Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market
    • 8.4.1 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.4.2 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.4.3 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.4.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.5 South Africa Non-invasive Prenatal Testing (NIPT) Market
    • 8.5.1 South Africa Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.5.2 South Africa Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.5.3 South Africa Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.5.4 South Africa Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.6 Nigeria Non-invasive Prenatal Testing (NIPT) Market
    • 8.6.1 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.6.2 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.6.3 Nigeria Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.6.4 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.7 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market
    • 8.7.1 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.7.2 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.7.3 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.7.4 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology

Chapter 9. Company Profiles

  • 9.1 Illumina, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 Natera Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 PerkinElmer, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 Laboratory Corporation of America Holdings
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental Analysis
    • 9.5.4 SWOT Analysis
  • 9.6 Eurofins Scientific SE
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Product Launches and Product Expansions:
    • 9.6.5 SWOT Analysis
  • 9.7 Thermo Fisher Scientific, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 WOT Analysis
  • 9.8 GE HealthCare Technologies, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
      • 9.8.5.2 Acquisition and Mergers:
    • 9.8.6 SWOT Analysis
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Pacific Biosciences of California, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Acquisition and Mergers:
    • 9.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Consumables & Reagents Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Consumables & Reagents Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Instruments Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Instruments Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Trisomy Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Trisomy Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Microdeletion Syndrome Market by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Microdeletion Syndrome Market by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Next Generation Sequencing (NGS) Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Next Generation Sequencing (NGS) Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Microarray Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Microarray Market by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Polymerase Chain Reaction (PCR) Market by Country, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Polymerase Chain Reaction (PCR) Market by Country, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Rolling Circular Amplification Market by Country, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Rolling Circular Amplification Market by Country, 2023 - 2030, USD Million
  • TABLE 33 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2022, USD Million
  • TABLE 34 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country, 2023 - 2030, USD Million
  • TABLE 35 Brazil Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 36 Brazil Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 37 Brazil Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 38 Brazil Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 39 Brazil Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 40 Brazil Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 41 Brazil Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 42 Brazil Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 43 Brazil Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 44 Brazil Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 45 Argentina Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 46 Argentina Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 47 Argentina Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 48 Argentina Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 49 Argentina Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 50 Argentina Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 51 Argentina Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 52 Argentina Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 53 Argentina Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 54 Argentina Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 55 UAE Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 56 UAE Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 57 UAE Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 58 UAE Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 59 UAE Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 60 UAE Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 61 UAE Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 62 UAE Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 63 UAE Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 64 UAE Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 65 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 66 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 67 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 68 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 69 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 70 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 71 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 72 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 73 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 74 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 75 South Africa Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 76 South Africa Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 77 South Africa Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 78 South Africa Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 79 South Africa Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 80 South Africa Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 81 South Africa Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 82 South Africa Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 83 South Africa Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 84 South Africa Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 85 Nigeria Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 86 Nigeria Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 87 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 88 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 89 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 90 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 91 Nigeria Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Nigeria Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 94 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 95 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 96 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 97 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 98 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 99 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 100 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 101 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 102 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 103 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 104 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 105 key information - Illumina, Inc.
  • TABLE 106 Key Information - Natera Inc.
  • TABLE 107 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 108 key Information - PerkinElmer, Inc.
  • TABLE 109 Key Information - Laboratory Corporation of America holdings
  • TABLE 110 Key Information - Eurofins Scientific SE
  • TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 112 Key Information - GE HealthCare Technologies, Inc.
  • TABLE 113 key Information - Agilent Technologies, Inc.
  • TABLE 114 Key Information - Pacific Biosciences of California, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!